The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK PM Says Gradual Lift Of Lockdown May Take To End Of March

Wed, 06th Jan 2021 13:03

(Alliance News) - UK Prime Minister Boris Johnson warned it will take time to ease lockdown restrictions in England which could be in place until the end of March.

Johnson said there was "no choice" but to issue the stay-at-home order and close schools given the spread of coronavirus, particularly the more infectious new variant.

Addressing members of Parliament after the recall of the Commons from its Christmas break, Johnson said there was now a race between the spread of the virus and the delivery of vaccines to the most vulnerable.

England's lockdown has already come into force and MPs will vote later to retrospectively approve it.

Johnson said: "Our emergence from the lockdown cocoon will not be a big bang but a gradual unwrapping.

"That is why the legislation this House will vote on later today runs until March 31 – not because we expect the full national lockdown to continue until then but to allow a steady, controlled and evidence-led move down through the tiers on a regional basis."

The prime minister told MPs there would be "continuous review" of the measures with a statutory requirement to look at them every fortnight and a legal obligation to remove them if they are no longer necessary.

"We are in a tough final stretch, made only tougher by the new variant," Johnson said.

"After the marathon of last year we are indeed now in a sprint, a race to vaccinate the vulnerable faster than the virus can reach them.

"Every needle in every arm makes a difference."

Despite calls from Speaker Lindsay Hoyle to stay away from the Chamber and participate remotely, the Conservative benches were well attended.

Johnson believes the rollout of vaccines will provide a route out of lockdown, but his approach was questioned by the World Health Organisation.

The government is giving the vaccine to as many priority patients as possible with a second shot after 12 weeks, rather than holding back supplies to offer the booster dose three weeks after the first jab.

The WHO said it would not recommend that approach, instead suggesting the interval should be between three and four weeks.

Vaccines minister Nadhim Zahawi said the government had a "stretching" target of vaccinating 14 million people in the highest priority groups – the elderly, those with clinical needs, care home residents and staff and frontline NHS workers – by February 15.

Some 1.3 million people have already received either the Pfizer Inc and BioNTech SE or Oxford University and AstraZeneca PLC jab.

The government wants England's schools to reopen after the February half-term starting that week, but experts warned that would depend on progress in the battle to curb Covid-19 cases.

GCSE and A-level examinations in England will not take place as a result of the disruption.

The prime minister faces pressure from some Conservatives to ease the lockdown as soon as possible.

Former chief whip Mark Harper, chairman of the Covid Recovery Group of lockdown sceptics, used a Telegraph article to call for a "substantial relaxation" of restrictions as soon as the four top priority groups have been vaccinated.

Fellow CRG member Steve Baker said: "Once the most vulnerable have been vaccinated, draconian restrictions must be substantially removed."

Graham Brady, chairman of the influential 1922 Committee of backbench Tories, called for Commons votes at the end of January and February on whether the restrictions should continue.

Johnson told MPs there would be "substantial opportunities for relaxing the restrictions" before the end of March.

In other developments:

– One in four deaths in England and Wales registered in the week leading up to Christmas – some 2,912 – involved coronavirus Office for National Statistics figures showed.

– The Metropolitan Police indicated a tougher approach to those flouting the lockdown, with officers expected to be more "inquisitive" about why people are "out and about".

– The European Medicines Agency cleared the way for the Moderna Inc vaccine to be used in the EU, but following the end of the Brexit transition period on December 31 this will not apply in the UK.

England's lockdown measures will be approved by MPs despite some reservations on the Tory benches.

Labour leader Keir Starmer backed the restrictions, saying: "The virus is out of control, over a million people in England now have Covid, the number of hospital admissions is rising, tragically so are the numbers of people dying.

"And it's only the early days of January and the NHS is under huge strain. In those circumstances, tougher restrictions are necessary."

But he added "this is not just bad luck, it's not inevitable, it follows a pattern" of the government being slow to respond.

England's chief medical officer, Chris Whitty, has warned some restrictions may have to be introduced again next winter.

Graham Medley, professor of infectious disease modelling at the London School of Hygiene and Tropical Medicine, and a member of the Scientific Advisory Group for Emergencies, agreed and said "we're in for a long haul" in the fight with coronavirus.

He told BBC Radio 4's Today: "Vaccination is a way out, but I think he's right to raise that possibility that there could be – next winter or even the winter after – the possibility that we will see a resurgence of Covid to such an extent that government again has to take measures to prevent another large outbreak."

By David Hughes, PA Political Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.